NEW YORK (GenomeWeb News) – Millennium Laboratories said today that it has acquired healthcare predictive analytics and decision support firm RxAnte.

RxAnte, a venture-backed startup, markets products to help health plans, pharmacy-benefit management companies, pharmacy chains, and healthcare providers improve patient adherence to treatments. Millennium, meanwhile, offers pharmacogenetic testing for pain treatment, substance abuse disorders, psychiatric conditions, and various chronic diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.